期刊文献+

红景天最细粉对糖尿病肾病模型大鼠的保护作用 被引量:8

Renal protective effects of superfine powder of rhodiola rosea on diabetic nephropathy in rats
原文传递
导出
摘要 目的 研究红景天最细粉对糖尿病肾病(DN)大鼠的保护作用.方法 采用单侧肾脏切除并腹腔注射链脲佐菌素(STZ)的方法建立DN大鼠模型.将造模成功的大鼠按体质量排序编号,采用随机数字表法随机分为假手术组,DN模型组,红景天普通粉治疗组(3 g/kg·d-1),及红景天最细粉低剂量组(0.75 g/kg·d-1)、中剂量组(1.5 g/kg·d-1)、高剂量组(3 g/kg·d-1)各10只,均灌胃给药,1次/d.7周后,检测各组空腹血糖(FBG)、血清总胆固醇(STC)、尿素氮(BUN)、肌酐(Cr)、尿液尿蛋白(Upro);光镜观察各组肾组织的形态学改变.结果 DN模型组FBG、STC、BUN、Cr、Upro[分别为(24.78±3.66) mmol/L、(4.07±1.32) mmol/L、(22.36±2.54) mmol/L、(86.78±7.47) μmol/L、(50.23±6.82) mg],与红景天普通粉治疗组,红景天最细粉中、高剂量组的FBG[分别为(18.67±2.74) mmol/L、(17.21±3.17) mmol/L、(15.48±2.46) mmol/L]、STC[分别为(3.33±0.87) mmol/L、(3.42±0.74) mmol/L、(3.21±0.92) mmol/L],BUN[分别为(15.43±2.04) mmol/L、(16.56±1.85) mmol/L、(12.44±1.36) mmol/L]、Cr[分别为(66.17±4.43) μmol/L、(68.42±5.06) μmol/L、(61.33±4.21) μmol/L]、Upro[分别为(37.47±5.64) mg、(35.66±4.72) mg、(27.37±3.92) mg]比较均降低,差异有统计学意义(P<0.05),且红景天最细粉高剂量组的疗效更佳.DN大鼠肾组织病理形态学观察表明,各红景天治疗组肾组织病理改变均减轻.结论 红景天对DN大鼠有保护作用,且相同剂量最细粉组的疗效优于普通粉组. Objective To study the renal protective effects of superfine powder of Rhodiola rosea in diabetic nephropathy (DN)rats.Methods The DN rats model was established by one side nephrectomy and intraperitoneal injection of streptozotocin(STZ).Then rats were randomly divided into 6 groups:sham-operation group,model group,Rhodiola rosea common powder groups(3 g/kg·d-1),and superfine powder of low,medium and high dose groups (0.75、1.5、3.0 g/kg·d 1),10 rats in each group.Rats were given the relevant drugs respectively for 7 weeks.Finally the levels of fasting blood glucose (FBG),serum total cholesterol (STC),blood urea nitrogen (BUN),creatinine (Cr) and urinary protein (Upro) were detected.The kidney tissue was taken for histopathological observation.Results Compared with DN modelgroup [FBG,STC,BUN,Cr and Upro was (24.78±3.66)mmol/L,(4.07±1.32)mmol/L,(22.36±2.54)mmol/L,(86.78±7.47) μmol/L,(50.23±6.82)mg respectively],the rats in DN model group after treatment with common and superfine powder (medium and high dose groups) of Rhodiola rosea appeared different levels of improvement ofFBG [(18.67±2.74) mmol/L,(17.21 ±3.17)mmol/L,(15.48±2.46) mmol/L],STC [(3.33±0.87) mmol/L,(3.42 ± 0.74) mmol/L,(3.21 ±0.92)mmol/L],BUN [(15.43±2.04)mmol/L,(16.56±1.85)mmol/L,(12.44±1.36)mmol/L],Cr [(66.17 ± 4.43) μmol/L,(68.42 ± 5.06) μmol/L,(61.33±4.21)μmol/L] and Upro [(37.47±5.64) mg、(35.66 ± 4.72) mg,(27.37± 3.92) mg],P< 0.05.The pathologic changes of kidney tissue were improved,too.Conclusion Rhodiola rosea has a good renal protective effect in rats with DN.Furthermore,the superfine powder is more effective than the common powder in renal protective effects.
出处 《国际中医中药杂志》 2014年第2期121-124,共4页 International Journal of Traditional Chinese Medicine
基金 四川省中药研究促进会重点合作项目
关键词 红景天 最细粉 糖尿病肾病 保护作用 Rhodiola rosea Superfine powder Diabetic nephropathy Protective effects
  • 相关文献

参考文献12

二级参考文献155

共引文献118

同被引文献145

  • 1王亚茹,于世家.于世家教授治疗早期糖尿病肾病经验[J].实用中医内科杂志,2009(3). 被引量:9
  • 2王雪威,南红梅.南征教授治疗糖尿病肾病经验介绍[J].新中医,2005,37(5):14-15. 被引量:27
  • 3文镜,郭豫,常平.红景天提取物抗氧化作用的实验观察[J].中国临床康复,2005,9(11):125-127. 被引量:12
  • 4李琳,邓晓明,王淑玲.水蛭对糖尿病肾病大鼠尿微量白蛋白影响的机制[J].中国实用医刊,2010,37(13):62-63. 被引量:7
  • 5国家药典委员会.中国药典[S].一部.北京:中国医药科技出版社,2010:312-313.
  • 6Newsholme P, Haber E P, Hirabara S M, et al. Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity [J]. J Physiol, 2007, 583(Ptl): 9-24.
  • 7Lapshina E A, Sudnikovich E J, Maksimchik J Z, et al. Antioxidative enzyme and glutathione S-transferase activities in diabetic rots exposed to long-term ASA treatment [J]. Life Sci, 2006, 79(19): 1804-1811.
  • 8Anwar M M, Meki A R. Oxidative stress in streptozotocin- induced diabetic rats: effects of garlic oil and melatonin [J]. Comp Biochem Physiol A Mol Integr Physiol, 2003, 135(4): 539-547.
  • 9Yan S, Xu D, Zhang B, et al. Graph embedding and extensions: a general framework for dimensionality reduction [J]. IEEE Trans Pattern Anal Mach lntell, 2007, 29(1): 40-51.
  • 10Shakil A, Church R J, Rao S S. Gastrointestinal complications of diabetes [J]. Am Fam Physician, 2008, 77(12): 1697-1702.

引证文献8

二级引证文献80

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部